RE: Getting closer19 Oct 2020 21:21
Where have we heard this before:
bioscience firms that are members of BIVDA (the British In-Vitro Diagnostic Association) have indeed been asked by NHS Test and Trace to “repurpose” their manufacturing capabilities, amending processes for things like pregnancy tests to use their factories to produce the new Covid tests.
Two firms alone, BBI and Abingdon, will have a manufacturing capacity of upto seven million test a day, once issues like tech transfer are resolved and test sensitivity standards are passed.